Get in touch
Our Focus
Who We Are
Pipeline
Updates
Get in touch
Press Releases
All
Press Releases
Publications
Corporate Info
Sophrosyne Pharmaceuticals Announces Formation of Scientific Advisory Board Consisting of Preeminent Key Opinion Leaders
Nov 3, 2025
|
Press Releases
Sophrosyne Pharmaceuticals Receives FDA Clearance to Initiate Phase 1 Study with its Lead Product for the Treatment of Alcohol Use Disorder (AUD)
Sep 30, 2025
|
Press Releases
Sophrosyne Pharmaceuticals Appoints Herman Cukier as CEO
Aug 26, 2025
|
Press Releases
